TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress August 11, 2022
Renovia Receives FDA Clearance for leva® Pelvic Health System as First-line Treatment for Chronic Fecal Incontinence July 11, 2022
New Clinical Study Demonstrates Colorescience All Calm® Regimen Neutralizes Redness and Calms Inflamed Skin June 30, 2022
XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy for Ischemic Heart Disease June 30, 2022
